United Kingdom Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Report Summary

GlobalData’s new report, “United Kingdom Diabetes Care Devices Market Outlook to 2017Glucose Monitoring and Insulin Delivery” provides key market data on the United Kingdom Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for  Diabetes Care Devices  market categories – Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the United Kingdom Diabetes Care Devicesmarket.       
• Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Sanofi, Eli Lilly and Company, LifeScan, Inc., Becton, Dickinson and Company  and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the United Kingdom Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7

2 Introduction 9
2.1 What is This Report About? 9

3 Diabetes Care Devices In United Kingdom 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 11
3.3 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2010 13
3.4 Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2010 14
3.5 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 21
3.6 Diabetes Care Devices, United Kingdom, Company Share (2009-2010) 24

4 Glucose Monitoring In United Kingdom 26
4.1 Glucose Monitoring, Market Segmentation 26
4.2 Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2010 27
4.3 Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2010 28
4.4 Glucose Monitoring Overall Revenue (2003-2017) 29
4.4.1 Blood Glucose Meters Revenue (2003-2017) 33
4.5 Glucose Monitoring Overall Volume (2003-2017) 37
4.5.1 Blood Glucose Meters Volume (2003-2017) 41
4.6 Glucose Monitoring Average Price (2003-2017) 45
4.7 Glucose Monitoring Distribution Share (2009-2010) 46
4.8 Glucose Monitoring, United Kingdom, Company Share (2009-2010) 47

5 Insulin Delivery In United Kingdom 48
5.1 Insulin Delivery, Market Segmentation 48
5.2 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2010 49
5.3 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2010 50
5.4 Insulin Delivery Overall Revenue (2003-2017) 51
5.4.1 Insulin Pens Revenue (2003-2017) 55
5.4.2 Insulin Pumps Revenue (2003-2017) 59
5.5 Insulin Delivery Overall Volume (2003-2017) 63
5.5.1 Insulin Pens Volume (2003-2017) 67
5.5.2 Insulin Pumps Volume (2003-2017) 71
5.6 Insulin Delivery Average Price (2003-2017) 74
5.7 Insulin Delivery Distribution Share (2009-2010) 75
5.8 Insulin Delivery, United Kingdom, Company Share (2009-2010) 76

6 Overview of Key Companies in United Kingdom Diabetes Care Devices Market 78
6.1 F. Hoffmann-La Roche Ltd. 78
6.1.1 Company Overview 78
6.1.2 Share in the United Kingdom Diabetes Care Devices Market 78
6.2 Novo Nordisk A/S 79
6.2.1 Company Overview 79
6.2.2 Share in the United Kingdom Diabetes Care Devices Market 79
6.3 Sanofi 80
6.3.1 Company Overview 80
6.3.2 Share in the United Kingdom Diabetes Care Devices Market 80
6.4 Eli Lilly and Company 81
6.4.1 Company Overview 81
6.4.2 Share in the United Kingdom Diabetes Care Devices Market 81
6.5 LifeScan, Inc. 82
6.5.1 Company Overview 82
6.5.2 Share in the United Kingdom Diabetes Care Devices Market 82
6.6 Becton, Dickinson and Company 83
6.6.1 Company Overview 83
6.6.2 Share in the United Kingdom Diabetes Care Devices Market 83
6.7 Bayer HealthCare AG 84
6.7.1 Company Overview 84
6.8 Abbott Laboratories 84
6.8.1 Company Overview 84
6.9 Medtronic, Inc. 85
6.9.1 Company Overview 85
6.10 Animas Corporation 85
6.10.1 Company Overview 85
6.11 Ypsomed Holding AG 85
6.11.1 Company Overview 85
6.12 NIPRO CORPORATION 86
6.12.1 Company Overview 86
6.13 ARKRAY, Inc. 86
6.13.1 Company Overview 86
6.14 Terumo Corporation 86
6.14.1 Company Overview 86

7 Diabetes Care Devices Market Pipeline Products 87

8 Financial Deals Landscape 91
8.1 Partnerships 91
8.1.1 Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 91
8.1.2 Midatech Enters Into Joint Venture With MonoSol Rx 92

9 Appendix 93
9.1 Definitions of Markets Covered in the Report 94
9.1.1 Diabetes Care Devices 94
9.2 Research Methodology 97
9.3 Secondary Research 97
9.4 Primary Research 98
9.5 Models 98
9.6 Forecasts 99
9.7 Expert Panels 99
9.8 GlobalData Consulting 99
9.9 Currency Conversion 100
9.10 Contact Us 100
9.11 Disclaimer 100

List of Tables

Table 1:Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 12
Table 2:Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2010 14
Table 3:Diabetes Care Devices, United Kingdom, Cross-Segment Analysis,2003-2017 16
Table 4:Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Historic, 2003-2010 18
Table 5:Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 20
Table 6:Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 21
Table 7:Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 22
Table 8:Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 23
Table 9:Diabetes Care Devices, United Kingdom, Company Share by Revenue ($m), USD Actual, 2009-2010 25
Table 10:Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2010 28
Table 11:Glucose Monitoring, United Kingdom, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 30
Table 12:Glucose Monitoring, United Kingdom, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 32
Table 13:Blood Glucose Meters, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 34
Table 14:Blood Glucose Meters, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 36
Table 15:Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 38
Table 16:Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 40
Table 17:Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 42
Table 18:Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 44
Table 19:Glucose Monitoring, United Kingdom, Average Price ($), Historic, 2003-2010 45
Table 20:Glucose Monitoring, United Kingdom, Average Price ($), Forecast, 2010-2017 45
Table 21:Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USD Actual, 2009-2010 46
Table 22:Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USD Actual 2009-2010 47
Table 23:Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2010 50
Table 24:Insulin Delivery, United Kingdom, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 52
Table 25:Insulin Delivery, United Kingdom, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 54
Table 26:Insulin Pens, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 56
Table 27:Insulin Pens, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 58
Table 28:Insulin Pumps, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 60
Table 29:Insulin Pumps, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 62
Table 30:Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 64
Table 31:Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 66
Table 32:Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 68
Table 33:Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 70
Table 34:Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 71
Table 35:Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 73
Table 36:Insulin Delivery, United Kingdom, Average Price ($), Historic, 2003-2010 74
Table 37:Insulin Delivery, United Kingdom, Average Price ($), Forecast, 2010-2017 74
Table 38:Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Actual, 2009-2010 75
Table 39:Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Actual 2009-2010 77
Table 40:Diabetes Care Devices Market Pipeline Products 87
Table 41:Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 91
Table 42:Midatech Enters Into Joint Venture With MonoSol Rx 92
Table 43: USD to Local Currency, United Kingdom, Average Actual Rate 2003-2010 100

List of Figures

Figure 1:Diabetes Care Devices, Market Segmentation 10
Figure 2:Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 11
Figure 3:Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2010 13
Figure 4:Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2010 14
Figure 5:Diabetes Care Devices, United Kingdom, Cross-Segment Analysis,2003-2017 15
Figure 6:Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Historic, 2003-2010 17
Figure 7:Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 19
Figure 8:Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 21
Figure 9:Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 22
Figure 10:Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 23
Figure 11:Diabetes Care Devices, United Kingdom, Company Share (%), 2010 24
Figure 12:Glucose Monitoring, Market Segmentation 26
Figure 13:Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2010 27
Figure 14:Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2010 28
Figure 15:Glucose Monitoring, United Kingdom, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 29
Figure 16:Glucose Monitoring, United Kingdom, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 31
Figure 17:Blood Glucose Meters, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 33
Figure 18:Blood Glucose Meters, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 35
Figure 19:Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 37
Figure 20:Glucose Monitoring, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 39
Figure 21:Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 41
Figure 22:Blood Glucose Meters, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 43
Figure 23:Glucose Monitoring, United Kingdom, Company Share (%), 2010 47
Figure 24:Insulin Delivery, Market Segmentation 48
Figure 25:Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2010 49
Figure 26:Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2010 50
Figure 27:Insulin Delivery, United Kingdom, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 51
Figure 28:Insulin Delivery, United Kingdom, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 53
Figure 29:Insulin Pens, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 55
Figure 30:Insulin Pens, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 57
Figure 31:Insulin Pumps, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 59
Figure 32:Insulin Pumps, United Kingdom, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 61
Figure 33:Insulin Delivery, United Kingdom, Volume (Units) by Segment, Historic, 2003-2010 63
Figure 34:Insulin Delivery, United Kingdom, Volume (Units) by Segment, Forecast, 2010-2017 65
Figure 35:Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Figure 36:Insulin Pens, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Figure 37:Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2003-2010 71
Figure 38:Insulin Pumps, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2010-2017 72
Figure 39:Insulin Delivery, United Kingdom, Company Share (%), 2010 76
Figure 40:F. Hoffmann-La Roche Ltd., Company Share (%),United Kingdom Diabetes Care Devices Market, 2010 78
Figure 41:Novo Nordisk A/S, Company Share (%),United Kingdom Diabetes Care Devices Market, 2010 79
Figure 42:Sanofi, Company Share (%),United Kingdom Diabetes Care Devices Market, 2010 80
Figure 43:Eli Lilly and Company, Company Share (%),United Kingdom Diabetes Care Devices Market, 2010 81
Figure 44:LifeScan, Inc., Company Share (%),United Kingdom Diabetes Care Devices Market, 2010 82
Figure 45:Becton, Dickinson and Company, Company Share (%),United Kingdom Diabetes Care Devices Market, 2010 83